Business Context and Reporting Period
Company: MICROVISION, INC.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2001
Business Overview: Microvision develops information display and capture technologies, primarily focusing on Retinal Scanning Displays (RSD) for defense, medical, and consumer applications. The company also operates a subsidiary, Lumera Corporation, which develops electro-optical materials for telecommunications. As of the reporting date, the company was in a development stage, generating revenue primarily from government and commercial development contracts rather than commercial product sales.
Key Financial Metrics
| Metric (in thousands) | 2001 | 2000 |
|---|---|---|
| Revenue | $10,762 | $8,121 |
| Cost of Revenue | $6,109 | $6,076 |
| Gross Margin | $4,653 (43%) | $2,045 (25%) |
| Net Loss | $(34,794) | $(26,601) |
| Net Loss Per Share (Basic/Diluted) | $(2.85) | $(2.33) |
| Cash, Cash Equivalents & Investments | $33,652 | $40,717 |
| Working Capital | $33,098 | $40,551 |
| Total Assets | $54,055 | $56,172 |
| Long-term Obligations | $552 | $714 |
| Accumulated Deficit | $(100,931) | $(66,137) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 33% to $10.8 million, driven by a higher volume of development contracts, particularly with the U.S. government (which accounted for 93% of revenue).
- Increased Losses: Net loss widened to $34.8 million from $26.6 million. This was primarily due to a 63% increase in Research and Development (R&D) expenses to $31.9 million and a 37% increase in Marketing, General, and Administrative (MG&A) expenses to $14.4 million.
- R&D Drivers: Significant R&D spending included a $1.1 million expense for the "HALO" technology license and $2.0 million amortization related to the Lumera Sponsored Research Agreement with the University of Washington.
- Liquidity: Cash and investment balances decreased by approximately $7 million year-over-year, largely due to operating cash outflows of $35.0 million, partially offset by financing activities (stock issuances) totaling $32.5 million.
Guidance, Outlook, and Risks
- Outlook: Management expects to incur significant losses in 2002. The company anticipates generating material revenue from product sales in 2002 with the planned introduction of the "NOMAD" head-worn display and a handheld bar code scanner.
- Capital Needs: The company stated it will require additional capital to fund R&D, manufacturing capacity, and sales/marketing expansion. It raised $6.0 million in March 2002 (subsequent to year-end) to extend its cash runway.
- Key Risks:
- Market Acceptance: No assurance that retinal scanning or optical materials technologies will achieve commercial viability.
- Government Dependence: 93% of revenue is derived from U.S. government contracts, which are subject to funding delays and termination for convenience.
- Intellectual Property: Reliance on exclusive licenses from the University of Washington; loss of exclusivity would materially harm the business.
- Competition: Intense competition from established display manufacturers (e.g., Sony, Texas Instruments) with greater resources.
Investor Verification Checklist
- Cash Runway: Verify if the $33.7 million cash balance plus the $6.0 million raised in March 2002 is sufficient to fund operations through the commercialization of the NOMAD product.
- Contract Backlog: Confirm the status of the $6.8 million backlog (as of Dec 31, 2001) and the likelihood of full execution in 2002.
- Product Commercialization: Assess the timeline and market reception for the NOMAD display and the handheld bar code scanner, as these are critical for transitioning from contract-based to product-based revenue.
- Lumera Subsidiary: Review the financial health and progress of Lumera Corporation, which incurred significant losses and relies on Microvision for funding.
- Stock Dilution: Monitor future equity issuances, as the company has a history of raising capital through stock sales, which dilutes existing shareholders.